Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:52 AM
Ignite Modification Date:
2025-12-24 @ 11:52 AM
NCT ID:
NCT01199861
Eligibility Criteria:
Inclusion Criteria:
* Must have relapsing MS
* Must have lifetime tetanus vaccination
* Agree to receive 2010/2011 seasonal influenza vaccine and tetanus toxoid booster injection
Exclusion Criteria:
* Patients with a type of MS that is not relapsing
* Patients with history of chronic immune disease
* Certain cancers
* Diabetic patients with certain eye disorders
* Patients who are on certain immunosuppressive medications or heart medications
* Patients with certain heart conditions
* Patients with certain lung conditions
* Patients who have already received the 2010/2011 seasonal influenza vaccine
Other protocol-defined inclusion/exclusion criteria may apply
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT01199861
Study Brief:
Protocol Section:
NCT01199861